News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eli Lilly and Company (LLY)'s Erbitux Fails In European Colon Cancer Study


10/11/2010 7:56:58 AM

MILAN, Oct 10 (Reuters) - Two small European studies cast doubt on the benefits of two key bowel cancer drugs on Sunday, puzzling experts at Europe's biggest cancer meeting in Milan.

Read at Reuters
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES